Used in the synthesis of pharmaceutical intermediates, particularly in the development of neuropharmaceuticals targeting glutamate receptors. Its chiral structure makes it valuable in creating selective enzyme inhibitors and receptor modulators. Commonly employed in research for designing drugs that treat neurological disorders such as epilepsy, neuropathic pain, and neurodegenerative diseases. Also utilized as a building block in peptidomimetic compounds to enhance metabolic stability and bioavailability.